This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Childhood Stimulant Treatment and Risk for Later Substance Abuse

Mariellen Fischer, PhD, Russell A. Barkley, PhD

Published: September 1, 2003

Article Abstract

Conflicting studies of the relationship between therapeutic use of psychostimulant medication and substance abuse have long been a subject of concern among clinicians and researchers. One controlled longitudinal study examined this relationship in 147 patients who were diagnosed with hyperactivity as young children and were surveyed with regard to their substance use both as adolescents and as adults. This study found that stimulant therapy for attention-deficit/hyperactivity disorder in childhood is not associated with increased risk of adolescent experimentation with substance use, frequency of such use, or the risk of developing psychoactive substance use disorders by young adulthood. Moreover, stimulant therapy in high school may well have provided a protective effect against hallucinogen abuse by adulthood. A possible explanation for contradictory findings previously published was suggested by the existence of a number of potentially confounding variables, particularly conduct disorders, for which prior studies have failed to control.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 5

Quick Links: Addiction , Substance Use Disorders


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional...